サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1394004

北米の構造的心臓市場の2028年までの予測- 地域別分析- 製品別、手技別、エンドユーザー別

North America Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 133 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
北米の構造的心臓市場の2028年までの予測- 地域別分析- 製品別、手技別、エンドユーザー別
出版日: 2023年10月10日
発行: The Insight Partners
ページ情報: 英文 133 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の構造的心臓市場は、2022年の69億6,750万米ドルから2028年には112億147万米ドルに成長すると予測されています。2022年から2028年までのCAGRは8.2%と推定されます。

革新的な構造的心臓サービスの利用可能性が北米の構造的心臓市場を後押し

世界保健機関（WHO）によると、心血管疾患は世界第2位の死因です。そのため、心血管疾患をコントロールするためにさまざまな取り組みが行われています。心臓弁膜症は、心不全の最も一般的な原因のひとつになると予想されています。大動脈弁や僧帽弁の変性疾患や三尖弁の機能不全疾患は、重症例では臨床経過を悪化させる。構造的心疾患に対する低侵襲的、外科的、カテーテル的介入は最近劇的に増加しています。構造的心臓は心臓弁手術や経カテーテル治療からなる発展途上の分野であるため、心臓外科医や内科医を対象としたさまざまなトレーニングプログラムが用意されています。過去10年間で、構造的心疾患の発生率が急増しているため、適切な能力を備えた人材を確保するための正式な研修プログラムの開発が必要となっています。トレーニングの構成、期間、範囲はプログラムによって大きく異なります。ほとんどのプログラムでは、経カテーテル的大動脈弁置換術（TAVR）をしっかり学ぶと同時に、心房中隔欠損や心室中隔欠損の閉鎖術、左心房付属器の閉鎖術、先天性心疾患のインターベンションについては、それほど多くはないが、さまざまな経験を積むことができます。TAVR、MitraClip僧帽弁修復システム（Abbott Vascular社製）、左心房付属器閉塞術（LAAO）の出現により、複雑な心血管系疾患を有する患者の治療のために行われる構造的心臓手術の量は大幅に増加しています。多くの組織では、患者の流入に対応するために、構造的心臓プログラムのための組織化された形式でサービスや手技の提供を展開しています。SHDのトレーニングはエキサイティングでやりがいがあり、全体としてやりがいのあるものです。この分野が発展するにつれて、SHDトレーニングの標準化は、患者ケアの最高の質を保証するために非常に重要になってくる。トレーニングから実践への移行を成功させるためには、多くの考慮事項をナビゲートしてくれる指導者を見つけることが何よりの財産となります。

北米の構造的心臓市場の概要

北米の構造的心臓市場は、2022年から2028年にかけてCAGR 8.2％で成長すると推定されます。市場成長を促進する主な要因は、革新的な構造的心臓サービス、心血管疾患数とトレーニングプログラムの増加です。しかし、構造的心臓装置に関する厳しい規制が続く処置の高コストが、市場の成長を妨げる主な要因となっています。

北米の構造的心臓市場の2028年までの収益と予測（金額）

北米の構造的心臓市場のセグメンテーション

北米の構造的心臓市場は、製品、手技、エンドユーザー、国に区分されます。

製品別では、北米の構造的心臓市場はオクルーダー、環状形成リング、心臓弁バルーン、その他に区分されます。2022年の北米の構造的心臓市場では、オクルーダセグメントが最大のシェアを占めています。

手技別に見ると、北米の構造的心臓市場は心臓弁狭窄症、心臓弁逆流症、左心房付属器閉鎖不全症に区分されます。心臓弁狭窄症セグメントは、2022年の北米の構造的心臓市場で最大のシェアを占めました。

エンドユーザー別に見ると、北米の構造的心臓市場は病院、外来手術センター、その他に区分されます。病院セグメントが2022年の北米の構造的心臓市場で最大のシェアを占めました。

国別では、北米の構造的心臓市場は米国、カナダ、メキシコに区分されます。米国が2022年の北米の構造的心臓市場を独占しました。

Abbott Laboratories、Medtronic Plc、Boston Scientific Corp、Artivion Inc、Edwards Lifesciences Corp、Lepu Medical Technology Beijing Co Ltd、Braile Biomedica Industry, Commerce and Representations Ltd、Micro Interventional Devices Incは、北米の構造的心臓市場で事業を展開する大手企業の一部です。

目次

第1章 イントロダクション

第2章 北米の構造的心臓市場- 主要なポイント

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の構造的心臓市場- 市場情勢

  • 概観
  • PEST分析
    • 北米のPEST分析
  • 専門家の見解

第5章 北米の構造的心臓市場-主要市場力学

  • 市場促進要因
    • 革新的な構造的心臓サービスの利用可能性
    • 心血管疾患症例の増加とトレーニングプログラム
  • 主な市場抑制要因
    • 手術費用の高騰
    • 構造的心臓装置に関する厳しい規制
  • 主な市場機会
    • 構造的心臓における人工知能の利用拡大
  • 今後の動向
    • 構造的心臓デバイス分野における技術の進歩
  • 影響分析

第6章 北米の構造的心臓市場-北米分析

  • 北米の構造的心臓市場の収益の予測と分析

第7章 北米の構造的心臓市場-2028年までの収益と予測：製品別

  • 構造的心臓の概要
  • 北米の構造的心臓市場：収益シェア、製品別、2021年および2028年
  • オクルーダー
  • 環状形成リング
  • 心臓弁バルーン
  • その他

第8章 北米の構造的心臓市場- 2028年までの収益と予測：手技別

  • 北米の構造的心臓市場：収益シェア、手技別、2021年および2028年
  • 心臓弁狭窄症
  • 心臓弁逆流
  • 左心房付属器閉鎖

第9章 北米の構造的心臓市場- 2028年までの収益と予測：エンドユーザー別

  • 北米の構造的心臓市場：収益シェア、エンドユーザー別、2021年および2028年
  • 病院
  • 外来手術センター
  • 心臓センター

第10章 北米の構造的心臓市場：2028年までの収益と予測：国別分析

  • 北米：北米の構造的心臓市場

第11章 北米の構造的心臓市場：業界情勢

  • 成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Lepu Medical Technology Beijing Co Ltd
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Micro Interventional Devices Inc

第13章 付録

図表

List Of Tables

  • Table 1. Structural Heart Training Programs in the US
  • Table 2. United States North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. United States North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. United States North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. United States North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. United States North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Recent Organic Growth Strategies in North America Structural Heart Market
  • Table 18. Glossary of Terms

List Of Figures

  • Figure 1. North America Structural Heart Market Segmentation
  • Figure 2. North America Structural Heart Market , by Country
  • Figure 3. North America Structural Heart Market Overview
  • Figure 4. Occluders Segment Held Largest Share of Product Segment in North America Structural Heart Market
  • Figure 5. North America: PEST Analysis
  • Figure 6. North America Experts' Opinion
  • Figure 7. North America Structural Heart Market : Impact Analysis of Drivers and Restraints
  • Figure 8. North America Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
  • Figure 9. North America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 10. Occluders: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. Annuloplasty Rings: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Heart Valve Balloons: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Others: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. North America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • Figure 15. Heart Valve Stenosis: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Heart Valve Regurgitation: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Left Atrial Appendage Closure: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. North America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 19. Hospitals: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Cardiac Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. North America: North America Structural Heart Market , by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. North America: North America Structural Heart Market , by Country, 2021 & 2028 (%)
  • Figure 24. United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028946

The North America structural heart market is expected to grow from US$ 6,967.50 million in 2022 to US$ 11,201.47 million by 2028. It is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

Availability of Innovative Structural Heart Services Fuel North America Structural Heart Market

According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death worldwide. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice.

North America Structural Heart Market Overview

The North America Structural heart market is estimated to grow at a CAGR of 8.2% from 2022 to 2028. Key factors driving the market growth are innovative structural heart services and rise in the number of cardiovascular diseases and training programs. However, high cost of procedure followed by stringent regulations regarding structure heart device are the major factor hampering the growth of the market.

North America Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

North America Structural Heart Market Segmentation

The North America structural heart market is segmented into product, procedure, end user, and country.

Based on product, the North America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the North America structural heart market in 2022.

Based on procedure, the North America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the North America structural heart market in 2022.

Based on end user, the North America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the North America structural heart market in 2022.

Based on country, the North America structural heart market is segmented into US, Canada, and Mexico. US dominated the North America structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, Lepu Medical Technology Beijing Co Ltd, Braile Biomedica Industry, Commerce and Representations Ltd, and Micro Interventional Devices Inc are some of the leading companies operating in the North America structural heart market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America structural heart market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
    • 1.2.1 North America Structural Heart Market - by Product
    • 1.2.2 North America Structural Heart Market - by Procedure
    • 1.2.3 North America Structural Heart Market - by End User
    • 1.2.4 North America Structural Heart Market - by Country

2. North America Structural Heart Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Structural Heart Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Expert's Opinion

5. North America Structural Heart Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Availability of Innovative Structural Heart Services
    • 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Procedures
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in the Field of Structural Heart Devices
  • 5.5 Impact analysis

6. North America Structural Heart Market -North America Analysis

  • 6.1 North America Structural Heart Market Revenue Forecast and Analysis

7. North America Structural Heart Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 North America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Occluders
    • 7.3.1 Overview
    • 7.3.2 Occluders: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Annuloplasty Rings
    • 7.4.1 Overview
    • 7.4.2 Annuloplasty Rings: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Heart Valve Balloons
    • 7.5.1 Overview
    • 7.5.2 Heart Valve Balloons: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

  • 8.1 Overview
  • 8.2 North America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • 8.3 Heart Valve Stenosis
    • 8.3.1 Overview
    • 8.3.2 Heart Valve Stenosis: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Heart Valve Regurgitation
    • 8.4.1 Overview
    • 8.4.2 Heart Valve Regurgitation: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Left Atrial Appendage Closure
    • 8.5.1 Overview
    • 8.5.2 Left Atrial Appendage Closure: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Structural Heart Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 North America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiac Centers
    • 9.5.1 Overview
    • 9.5.2 Cardiac Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis

  • 10.1 North America: North America Structural Heart Market
    • 10.1.1 Overview
      • 10.1.1.1 United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 United States: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
        • 10.1.1.1.4 United States: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.1.5 United States: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.1.6 United States: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.1.7 United States: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)
      • 10.1.1.2 Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Canada: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Canada: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Canada: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.2.6 Canada: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.2.7 Canada: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)
      • 10.1.1.3 Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 Mexico: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
        • 10.1.1.3.4 Mexico: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
        • 10.1.1.3.5 Mexico: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.1.3.6 Mexico: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.1.3.7 Mexico: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)

11. North America Structural Heart Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Artivion Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Braile Biomedica Industry, Commerce and Representations Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Micro Interventional Devices Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms